Jakob Lange, Tobias Nemeth Ypsomed AG, Burgdorf, Switzerland Background: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a user population of both naïve and experienced users across a range of ages. The goals of the study were to evaluate whether users could use the devices safely and effectively relying on the instructions for use (IFU) for guidance, as well as to benchmark the device against another similar injector established in the market. Further objectives were to capture any usability issues and obtain participants’ s...
Background: Anti-tumor necrosis factor (anti-TNF) adherence is suboptimal. ava®, a reusable electrom...
Estella M Davis, Emily L Sexson, Mikayla L Spangler, Pamela A ForalDepartment of Pharmacy Practice, ...
Michael N Travanty,1 Bryon Calawa,2 Waleed S Shalaby,3 Michael J Jozwiakowski,3 Kyle B Haraldsen4 1P...
Jakob Lange,1 Philipp Richard,1 Nick Bradley2 1Ypsomed AG, Burgdorf, Switzerland; 2BERGO UK, Bearsde...
<p><b>Objectives</b>: Past research has emphasized injection force as a clinically highly relevant t...
The Aluetta™ reusable pen device and instructions for use (IFU) for growth hormone (r-hGH; Saizen®, ...
Maritta Sauer,1 Carole Abbotts2 1Global Strategic Insights, Merck KGaA, Darmstadt, Germ...
Florence Schwarzenbach,1 Michèle Dao Trong,1 Laurent Grange,2 Philippe E Laurent,3 Herve Abry...
Robert Rapaport,1 Paul Saenger,2 Heinrich Schmidt,3 Yukihiro Hasegawa,4 Michel Colle,5 Sandro Loche,...
Purpose: The study aimed to develop a motion capture system that can track, visualize, and analyze t...
Pens and autoinjectors are mainly used for the subcutaneous delivery of biopharmaceuticals, primaril...
Cecile Berteau1, Florence Schwarzenbach1, Yves Donazzolo2, Mathilde Latreille2, Julie Berube3, Herve...
Xiao Xiao,1 Wei Li,1 Corbin Clawson,2 David Karvani,2 Perceval Sondag,3 James K Hahn1,4 1Department...
Kristina Callis Duffin,1 Michael Bukhalo,2 Margaret A Bobonich,3 David Shrom,4 Fangyi Zhao,4 James R...
Objective: To assess usability, bioavailability, and safety of subcutaneous self-administration of 0...
Background: Anti-tumor necrosis factor (anti-TNF) adherence is suboptimal. ava®, a reusable electrom...
Estella M Davis, Emily L Sexson, Mikayla L Spangler, Pamela A ForalDepartment of Pharmacy Practice, ...
Michael N Travanty,1 Bryon Calawa,2 Waleed S Shalaby,3 Michael J Jozwiakowski,3 Kyle B Haraldsen4 1P...
Jakob Lange,1 Philipp Richard,1 Nick Bradley2 1Ypsomed AG, Burgdorf, Switzerland; 2BERGO UK, Bearsde...
<p><b>Objectives</b>: Past research has emphasized injection force as a clinically highly relevant t...
The Aluetta™ reusable pen device and instructions for use (IFU) for growth hormone (r-hGH; Saizen®, ...
Maritta Sauer,1 Carole Abbotts2 1Global Strategic Insights, Merck KGaA, Darmstadt, Germ...
Florence Schwarzenbach,1 Michèle Dao Trong,1 Laurent Grange,2 Philippe E Laurent,3 Herve Abry...
Robert Rapaport,1 Paul Saenger,2 Heinrich Schmidt,3 Yukihiro Hasegawa,4 Michel Colle,5 Sandro Loche,...
Purpose: The study aimed to develop a motion capture system that can track, visualize, and analyze t...
Pens and autoinjectors are mainly used for the subcutaneous delivery of biopharmaceuticals, primaril...
Cecile Berteau1, Florence Schwarzenbach1, Yves Donazzolo2, Mathilde Latreille2, Julie Berube3, Herve...
Xiao Xiao,1 Wei Li,1 Corbin Clawson,2 David Karvani,2 Perceval Sondag,3 James K Hahn1,4 1Department...
Kristina Callis Duffin,1 Michael Bukhalo,2 Margaret A Bobonich,3 David Shrom,4 Fangyi Zhao,4 James R...
Objective: To assess usability, bioavailability, and safety of subcutaneous self-administration of 0...
Background: Anti-tumor necrosis factor (anti-TNF) adherence is suboptimal. ava®, a reusable electrom...
Estella M Davis, Emily L Sexson, Mikayla L Spangler, Pamela A ForalDepartment of Pharmacy Practice, ...
Michael N Travanty,1 Bryon Calawa,2 Waleed S Shalaby,3 Michael J Jozwiakowski,3 Kyle B Haraldsen4 1P...